Znanost temeljena na dokazima u nefrologiji, dijalizi i transplantaciji bubrega

Abstract

Sažetak. Nefrologija je mlada grana interne medicine čiji razvoj započinje 60-ih godina prošlog stoljeća uvođenjem nadomještanja bubrežne funkcije u svakodnevnu kliničku praksu. Nakon gotovo pola stoljeća i publiciranog velikog broja studija pokazalo se da je velik broj njih upitne kvalitete te je zaključeno da nefrološkoj struci nedostaju randomizirane studije visoke kvalitete. Učinjeno je niz akcija u suradnji i s nefrološkom Cochrane grupom s ciljem unapređenja struke te su date jasne preporuke za buduća klinička istraživanja. Nefrološka Cochrane grupa prihvatila je tri naslova naše grupe u Rijeci i u fazi smo izrade protokola o prevenciji kontrastne nefropatije.Ključne riječi: kontrastna nefropatija; kronična bubrežna bolest; nefrologija; randomizirane kontrolirane studije.Abstract. Nephrology is a young branch of internal medicine whose development began in the 60s of the last century by introducing the renal replacement therapy in everyday clinical practice. After nearly half a century of publicity, it has been shown that a large number of studies are of questionable quality and it has been concluded that the nephrology lacked randomized controlled trials of high quality. A series of actions were carried out in cooperation with the renal Cochrane group with the aim of advancing the profession and giving clear recommendations for future clinical research. Our group in Rijeka has three review titles accepted in the renal Cochrane group and we have been drafting a protocol on the prevention of contrast nephropathy.

Health in the function of fitness promotion in Serbia

“…Inactivity and obesity are increasing at a rapid rate, negatively affecting public health globally (Guthold, at al., 2018; NCD-RisC, 2017). In Serbia, 57,000 people die annually as a result of cardiovascular diseases (55.5% of all deaths), and as many as 46.5% of the population over the age of 25 have hypertension (Pavletić Peršić, et al, 2010). Viewed globally, more than 200 million people suffer from osteoporosis, and in Serbia, 375,000 women (Boričić, et al, 2014).…”